The 10 safer use rules

TL;DR

• Start no earlier than age 25 (brain maturation complete).
• Never daily — target maximum 1–2× per week.
• Vaporize instead of joint (no combustion products, no tobacco).
• Always known source; if unsure use drug checking (DIBS Zurich, CheckYourDrugs Bern).

LRCUG rules in detail

• Start as late as possible (>25 y) — Meier 2012 shows IQ loss with early frequent use.
• Frequency: less = better; daily use doubles dependence risk.
• Keep THC content low (<10 %) — Hines 2020 links high potency with psychosis risk.
• Don't inhale deeply or hold — no benefit, more tar.
• No tobacco mix (common in CH) — avoid nicotine dependence.
• Not before 25, not in pregnancy, not with family psychosis history.
• Never while driving, never at work.

Swiss legal framework and everyday practice

In Switzerland, the handling of THC-containing cannabis is strictly regulated by law, which has a direct impact on harm reduction in everyday life. While products with a total THC content of less than one percent are not subject to the Narcotics Act, a clear ban applies to psychoactive cannabis. Consumption by adults can be punished with a fixed penalty fine of one hundred francs within the framework of legal regulations, provided that the amount carried does not exceed ten grams. However, the cantonal authorities enforce these regulations differently in practice, which presents consumers with legal uncertainties.

A particularly critical aspect of safer use concerns participation in road traffic. In Switzerland, a strict zero-tolerance policy applies with a legal THC limit of 1.5 micrograms per litre of blood; if this limit is reached, an inability to drive is irrevocably assumed. Anyone who consumes cannabis must be aware that degradation products can still be detected in the body long after the psychoactive effect has worn off. The ongoing cantonal pilot trials, such as Züri Can or Weed Care in Basel, provide scientifically monitored frameworks to test controlled procurement and safe handling in everyday life.

• Strict zero-tolerance limit of 1.5 micrograms of THC per litre of blood in Swiss road traffic.
• Fixed penalty fine of one hundred francs for minor quantities of up to ten grams for adults.
• Regulated procurement and education within the framework of state-approved pilot projects in various cantons.
• Medical cannabis has been prescribable by doctors since August 2022 without a BAG exceptional permit.

Pharmacological interactions and dangers of mixed consumption

A central pillar of harm reduction is avoiding the simultaneous consumption of different psychoactive substances. Combining cannabis with alcohol or synthetic stimulants can trigger unpredictable interactions in the central nervous system. Alcohol, for example, accelerates the absorption of THC into the bloodstream, which can uncontrollably intensify the psychoactive effect and lead to circulatory collapse, nausea, and acute anxiety attacks. The combination with sedatives or antidepressants also carries significant health risks, as the depressant effects of the substances can mutually potentiate each other.

In addition to illegal substances, pharmacological interactions with everyday medications also play an important role. Cannabinoids are metabolised in the liver via the same enzyme systems as many common medicines. This can lead to a dangerous increase in the blood levels of other medications or diminish their efficacy. Consumers with chronic conditions should therefore have potential risks medically assessed in advance. In the event of acute symptoms of poisoning or severe adverse reactions, the Swiss emergency number 145 from Tox Info Suisse provides rapid and confidential professional support.

• Interactions with alcohol increase THC absorption and strain the cardiovascular system.
• Simultaneous use of medications can inhibit their metabolism in the liver and intensify side effects.
• Increased risk of psychological crises and panic reactions during mixed consumption with stimulants.
• Tox Info Suisse (emergency number 145) as the first point of contact for overdoses and poisoning.

Comparison of administration methods: Vaporisation versus oral intake

The choice of consumption method significantly influences the health risk as well as the onset and duration of effects. While traditional smoking releases highly carcinogenic substances and carbon monoxide due to combustion processes, vaporisation represents a significantly lower-emission alternative. A vaporizer heats the plant material only to the point where the cannabinoids evaporate without combustion occurring. This protects the respiratory tract and prevents the inhalation of tar. Nevertheless, vaporising is not entirely risk-free either, as the lungs continue to be stressed by hot vapour and concentrated active ingredients.

The oral intake of cannabis, for example through baked goods or extracts, carries its own unique risks, which are often underestimated. Since the onset of action is delayed as it passes through the digestive tract and the liver, it often takes one to two hours before the first effects are felt. This frequently tempts inexperienced consumers to redose prematurely, which can lead to severe, long-lasting overdoses. Furthermore, THC is converted in the liver into an even more potent form, which drastically extends the intensity and duration of the high compared to inhalation.

• Vaporisation avoids toxic combustion products, but requires precise temperature control.
• Delayed onset of action with oral ingestion increases the risk of accidental overdoses.
• Longer and more intense effects due to the hepatic conversion of THC during digestion.
• Completely avoiding tobacco mixtures prevents rapid nicotine addiction.

FAQ